Asset Details
Do you wish to reserve the book?
Measuring progress in cancer survival across Canadian provinces: Extending the cancer survival index to further evaluate cancer control efforts
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Measuring progress in cancer survival across Canadian provinces: Extending the cancer survival index to further evaluate cancer control efforts
Do you wish to request the book?
Measuring progress in cancer survival across Canadian provinces: Extending the cancer survival index to further evaluate cancer control efforts
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Measuring progress in cancer survival across Canadian provinces: Extending the cancer survival index to further evaluate cancer control efforts
2022
Overview
A comprehensive evaluation of progress in cancer survival for all cancer types combined in Canada has recently been accomplished. An analogous evaluation across Canadian provinces has yet to be conducted. For the most recent period, 2013 to 2017, the five-year CSI was highest in Ontario (64.1%) and Alberta (63.3%), and lowest in Nova Scotia (60.8%). Significant progress in the five-year CSI since the period from 1992 to 1996 was observed in each province; the largest increases occurred in Alberta (8.7 percentage points) and Ontario (8.6 percentage points). Alberta's increase improved its relative provincial ranking from eighth to second. The influence of prostate cancer on provincial changes in the CSI since the period from 2003 to 2007 varied considerably from strongly counterproductive in New Brunswick, Saskatchewan and Nova Scotia because of decreasing prostate cancer survival, to strongly productive in Manitoba.
